| PERIOD ENDING | 30-Sep-09 | 31-Mar-09 | 30-Sep-08 | 30-Jun-08 | | Total Revenue |
-
| 12,833 | 35,662 | 22,458 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 12,833 | 35,662 | 22,458 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 676 | 781 | 793 | 824 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (676) | 12,052 | 34,869 | 21,634 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (36) | (82) | | Earnings Before Interest And Taxes | 17,257 | 12,052 | 34,833 | 5,798 | | Interest Expense | (49) | 27 | 57 | 67 | | Income Before Tax | 17,306 | 12,025 | 34,776 | 5,731 | | Income Tax Expense | (420) | 17 | (34) | (49) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 70,506 | 12,008 | 34,810 | 5,780 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 17,726 | 12,008 | 34,810 | 5,780 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,726 | $12,008 | $34,810 | $5,780 |
|
0.34% Nasdaq 
0.57%
Income Statement
